Lysosome Inhibitors Enhance the Chemotherapeutic Activity of Doxorubicin in HepG2 Cells

Publisher： Karger

E-ISSN： 1421-9794|62|2|85-93

ISSN： 0009-3157

Source： Chemotherapy, Vol.62, Iss.2, 2016-10, pp. : 85-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondria-Targeting Drug Oligomycin Blocked P-Glycoprotein Activity and Triggered Apoptosis in Doxorubicin-Resistant HepG2 Cells

By  

Chemotherapy, Vol. 50, Iss. 2, 2004-06 ,pp. : 55-62

Karger

Access to resources Recommend Favorite

Cytotoxic and Apoptosis-Inducing Activity of Triterpene Glycosides from Holothuria scabra and Cucumaria frondosa against HepG2 Cells

By Wang Juanjuan   Han Hua   Chen Xiangfeng   Yi Yanghua   Sun Hongxiang  

Marine Drugs, Vol. 12, Iss. 8, 2014-07 ,pp. : 4274-4290

MDPI

Access to resources Recommend Favorite

The Mechanism by Which Amentoflavone Improves Insulin Resistance in HepG2 Cells

By Zheng Xiaoke   Ke Yingying   Feng Aozi   Yuan Peipei   Zhou Jing   Yu Yang   Wang Xiaolan   Feng Weisheng  

Molecules, Vol. 21, Iss. 5, 2016-05 ,pp. : 624-624

MDPI

Access to resources Recommend Favorite

Characterization and Purification of Bergamottin from Citrus grandis (L.) Osbeck cv. Yongjiazaoxiangyou and Its Antiproliferative Activity and Effect on Glucose Consumption in HepG2 cells

By Liu Yilong   Ren Chuanhong   Cao Yunlin   Wang Yue   Duan Wenyi   Xie Linfeng   Sun Chongde   Li Xian  

Molecules, Vol. 22, Iss. 7, 2017-07 ,pp. : 1227-1227

MDPI

Access to resources Recommend Favorite

Threshold for Antiproliferative and Proapoptotic Activity of Taxol in HepG2 Cells Expressing Human CYP3A4: Effect of P-Glycoprotein Transporters

By  

Pharmacology, Vol. 69, Iss. 3, 2003-09 ,pp. : 142-149

Karger

Access to resources Recommend Favorite